At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 328 enrolled
Drug / intervention
IDP-124 Lotion +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
In Brief
A Phase 3 clinical trial evaluating IDP-124 Lotion and IDP-124 Vehicle Lotion for Atopic Dermatitis. Completed, enrolled 328 participants across 1 site.
Detailed Summary
Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtopic Dermatitis
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 2017
Enrollment StartAug 2018
Primary CompletionMay 2020
TodayJul 2026
First PostedFeb 23, 2017
Enrollment StartAug 14, 2018
Primary CompletionMay 12, 2020
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 9.4 years ago
Interventions
IDP-124 Lotiondrug
IDP-124 Lotion, twice-daily application
IDP-124 Vehicle Lotiondrug
IDP-124 Vehicle Lotion, twice-daily application